Ayala Pharmaceuticals (ADXS) Stock Chart & Stock Price History → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ADXS Stock Alerts $0.57 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media Ayala Pharmaceuticals Stock Price Performance5 Day Performance+0.35%1 Month Performance-4.67%3 Month Performance-3.03%6 Month Performance-36.44%Year-To-Date Performance-14.24%1 Year Performance-55.83% Receive ADXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him ADXS Stock Chart for Tuesday, April, 23, 2024 ADXS Chart by TradingView Ayala Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$0.57$0.57$0.57$0.572,462 shs$6.15 million04/19/2024$0.57$0.57+0.35%$0.60$0.572,462 shs$6.15 million04/18/2024$0.65$0.57-11.70%$0.57$0.509,468 shs$6.13 million04/17/2024$0.60$0.65+7.40%$0.65$0.642,315 shs$6.94 million04/16/2024$0.67$0.60-10.03%$0.68$0.594,865 shs$6.46 million04/15/2024$0.67$0.67$0.67$0.614,675 shs$7.18 million Get the Latest News and Ratings for ADXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024$0.67$0.67+0.01%$0.67$0.614,675 shs$7.18 million04/11/2024$0.61$0.67+9.49%$0.67$0.662,955 shs$7.18 million04/10/2024$0.67$0.61-8.68%$0.61$0.61759 shs$6.56 million04/09/2024$0.61$0.67+10.05%$0.67$0.671,244 shs$7.18 million04/08/2024$0.61$0.61$0.61$0.6110,176 shs$6.53 million04/05/2024$0.63$0.61-3.19%$0.70$0.612,646 shs$6.53 million04/04/2024$0.64$0.63-2.03%$0.67$0.613,112 shs$6.74 million04/03/2024$0.64$0.64$0.65$0.632,736 shs$6.88 million04/02/2024$0.64$0.64$0.65$0.64304 shs$6.88 million04/01/2024$0.64$0.64$0.64$0.64304 shs$6.88 million03/29/2024$0.64$0.64$0.72$0.6416,416 shs$6.88 million03/28/2024$0.70$0.64-8.57%$0.72$0.6416,416 shs$6.88 million03/27/2024$0.71$0.70-1.41%$0.70$0.5423,879 shs$7.53 million03/26/2024$0.63$0.71+12.70%$0.71$0.5824,119 shs$7.63 million03/25/2024$0.60$0.63+5.00%$0.63$0.634,295 shs$6.77 million03/22/2024$0.59$0.60+1.69%$0.66$0.541,833 shs$6.45 million03/21/2024$0.60$0.59-1.67%$0.69$0.595,619 shs$6.34 million03/20/2024$0.62$0.60-3.56%$0.60$0.60485 shs$6.45 million03/19/2024$0.60$0.62+4.15%$0.63$0.604,962 shs$6.69 million03/18/2024$0.62$0.60-3.65%$0.62$0.5424,222 shs$6.42 million03/15/2024$0.67$0.67$0.68$0.6110,097 shs$7.20 million03/14/2024$0.70$0.67-4.29%$0.70$0.6710,097 shs$7.20 million03/13/2024$0.74$0.70-5.41%$0.72$0.6112,746 shs$7.53 million03/12/2024$0.72$0.74+2.78%$0.75$0.721,269 shs$7.96 million03/11/2024$0.77$0.72-6.75%$0.77$0.719,114 shs$7.74 million03/08/2024$0.77$0.77+0.27%$0.81$0.732,513 shs$8.30 million03/07/2024$0.75$0.77+2.67%$0.79$0.772,563 shs$8.28 million03/06/2024$0.76$0.75-1.92%$0.81$0.6429,187 shs$8.06 million03/05/2024$0.84$0.76-9.02%$0.85$0.769,568 shs$8.22 million03/04/2024$0.91$0.84-7.74%$0.89$0.8416,324 shs$9.04 million03/01/2024$0.86$0.91+5.81%$0.97$0.911,399 shs$9.80 million02/29/2024$0.86$0.86$0.95$0.8630,450 shs$9.26 million02/28/2024$0.86$0.86$0.87$0.862,099 shs$9.26 million02/27/2024$0.90$0.86-4.29%$0.90$0.865,700 shs$9.26 millionDon’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him02/26/2024$0.89$0.90+1.08%$0.90$0.887,221 shs$9.67 million02/23/2024$0.85$0.89+4.48%$0.90$0.865,002 shs$9.57 million02/22/2024$0.97$0.85-12.18%$0.91$0.7934,665 shs$9.16 million02/21/2024$0.79$0.97+23.10%$0.98$0.7975,631 shs$10.43 million02/20/2024$0.73$0.79+8.11%$0.88$0.7548,055 shs$8.47 million02/19/2024$0.73$0.73$0.75$0.6023,200 shs$7.84 million02/16/2024$0.60$0.73+21.28%$0.75$0.6023,261 shs$3.53 million02/15/2024$0.68$0.60-11.62%$0.68$0.6024,336 shs$2.91 million02/14/2024$0.67$0.68+1.49%$0.70$0.655,017 shs$3.29 million02/13/2024$0.92$0.67-27.17%$0.95$0.61110,242 shs$3.24 million02/12/2024$1.15$0.92-20.00%$1.05$0.7780,165 shs$4.45 million02/09/2024$1.07$1.15+7.48%$1.19$1.0525,205 shs$5.57 million02/08/2024$1.14$1.07-6.14%$1.18$1.0530,842 shs$5.18 million02/07/2024$1.31$1.14-12.98%$1.32$1.0989,053 shs$5.52 million02/06/2024$0.59$1.31+122.07%$1.49$0.90480,276 shs$6.34 million02/05/2024$0.55$0.59+7.36%$0.59$0.5216,768 shs$2.86 million02/02/2024$0.58$0.55-5.26%$0.60$0.555,271 shs$2.66 million02/01/2024$0.55$0.58+5.07%$0.63$0.558,559 shs$2.81 million01/31/2024$0.53$0.55+3.76%$0.56$0.535,346 shs$2.67 million01/30/2024$0.52$0.53+2.31%$0.53$0.522,614 shs$2.58 million01/29/2024$0.60$0.52-13.33%$0.61$0.5123,303 shs$2.52 million01/26/2024$0.60$0.60$0.64$0.582,683 shs$2.90 million01/25/2024$0.60$0.60$0.61$0.5628,148 shs$2.90 million01/24/2024$0.59$0.60+1.72%$0.67$0.5728,148 shs$2.90 million01/23/2024$0.60$0.59-1.70%$0.62$0.578,506 shs$2.86 million01/22/2024$0.61$0.60-2.26%$0.69$0.607,015 shs$2.90 million Related Companies: Can-Fite BioPharma Stock Price Chart eFFECTOR Therapeutics Stock Price Chart Tenax Therapeutics Stock Price Chart Graybug Vision Stock Price Chart Cadrenal Therapeutics Stock Price Chart Trevena Stock Price Chart Chemomab Therapeutics Stock Price Chart Shuttle Pharmaceuticals Stock Price Chart iBio Stock Price Chart Universe Pharmaceuticals Stock Price Chart Receive ADXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADXS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ayala Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.